Home
Venable LLP
Damineh Morsali, Ph.D.
Damineh Morsali, Ph.D.
Venable LLP
Chugai, Genentech, And Hoffmann-La Roche Dismiss Appeals Of Actemra® Patent IPR Final Written Decisions
29 Feb 2024 | United States
EYLEA® (Aflibercept) IPR And BPCIA Litigation Updates
22 Dec 2023 | United States
BPCIA Litigation Related To Proposed Eylea Biosimilar CT-P42 Filed
27 Nov 2023 | United States
Venable's BiologicsHQ Monthly Injection – September 2023
18 Oct 2023 | United States
Contact Details
New York
Website
New York
United States

  © Mondaq® Ltd 1994 - 2024. All Rights Reserved.